Categories: HealthcareNews

ARCPOINT CLOSES SALE OF OWNERSHIP STAKE IN NON-CORE ASSET

Greenville, South Carolina , Jan. 03, 2025 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) reports that it has now completed the sale of its 68% share ownership interest in Achieve Behavioral Health Greenville LLC, (“Achieve”) as originally announced December 30, 2024. In exchange for its ownership interest in Achieve, the Company received cash of US$360,000, plus the settlement of US$120,000 in amounts owing between ARCpoint and the buyers of the Achieve interest, for total consideration of US$480,000.

The Transaction was a Non-Arm’s Length Transaction in accordance with the policies of the TSXV. The Transaction also constituted a “related party transaction” within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions (“MI 61-101”). Notwithstanding the foregoing, the directors of the Company determined that the Transaction was exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 in reliance on the exemptions set forth in sections 5.5(a) and 5.7(1)(b) of MI 61-101.

About ARCpoint Inc.

ARCpoint is an innovative US-based health care company that leverages technology along with brick-and-mortar locations to give businesses and individual consumers access to convenient, cost-effective healthcare information and solutions with transparent, up-front pricing, so that they can be proactive and preventative with their health and well-being.

For more information, please contact:

ARCpoint Inc.
Jason Tong, Chief Financial Officer
Phone : (604) 889-7827
E-mail : invest@arcpointlabs.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release.

 

Staff

Recent Posts

Apollo Biowellness, Inc., Announces Expiration of Letter of Intent, Negotiations Continue

North Bergen, New Jersey--(Newsfile Corp. - January 7, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN)…

2 hours ago

Broadreach Medical Resources (BMR) Announces Rebrand to HarmonyRx, Reflecting a New Era of Clinical-First Pharmacy Benefit Management

New York, New York--(Newsfile Corp. - January 7, 2026) - Broadreach Medical Resources (BMR), a…

3 hours ago

Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development

SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB)…

3 hours ago

Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA)

FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned…

3 hours ago

Ovation Science Secures New Canadian Patent; Strengthening IP Position and Expanding Commercial Opportunities for Topical Cannabis Products

Canadian Patent Enhances Market Exclusivity and Licensing PotentialExpands Global Intellectual Property Portfolio Supporting Long-Term Revenue…

3 hours ago